Internal Medicine, Gastroenterology · Indiana, PA
NPI
1114903994
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1265 Wayne Ave, 119 Professional Center, Suite 301
Indiana, PA, 15701
Phone (724) 465-6650
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
856 services
Medicare patients, 2024
456
Average age 74
Drug cost, 2024
$1.6M
5,630 prescriptions
Company payments, 2025
$16K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirish A Amin was code 99214 (office e&m - established), 227 times for 215 patients. In total Shirish A Amin billed 856 services in 32 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 227 | 215 | $82.64 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 133 | 46 | $59.79 | $7,952 |
| 45380 Lower GI Endoscopy - Other | Facility | 112 | 112 | $135.74 | $15K |
| 43239 Upper GI Endoscopy | Facility | 81 | 80 | $53.32 | $4,319 |
| 99222 Hospital E&M - Initial | Facility | 61 | 55 | $93.83 | $5,724 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 44 | $12.56 | $553 |
| 45378 Lower GI Endoscopy - Other | Facility | 31 | 31 | $123.28 | $3,822 |
| 43248 Upper GI Endoscopy | Facility | 31 | 31 | $96.54 | $2,993 |
| 99213 Office E&M - Established | Office | 19 | 19 | $61.69 | $1,172 |
| 99204 Office E&M - New | Office | 18 | 18 | $112.84 | $2,031 |
| 99203 Office E&M - New | Office | 16 | 16 | $42.32 | $677 |
| 43235 Upper GI Endoscopy | Facility | 13 | 11 | $74.38 | $967 |
| 45390 Lower GI Endoscopy - Other | Facility | 13 | 13 | $243.65 | $3,168 |
| 45385 Colonoscopy - Lesion Removal | Facility | 13 | 13 | $161.09 | $2,094 |
By year: 2022 $88K for 936 services; 2023 $78K for 847 services; 2024 $75K for 856 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirish A Amin prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,299 prescriptions and refills. In total Shirish A Amin wrote 5,630 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,299 | 3,194 | 354 | $21K |
| Famotidine Generic | 1,106 | 2,931 | 346 | $14K |
| Omeprazole Generic | 567 | 1,510 | 158 | $8,702 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 434 | 434 | 425 | $30K |
| Citalopram Hbr Citalopram Hydrobromide | 235 | 560 | 61 | $1,514 |
| Dicyclomine Hcl Generic | 190 | 251 | 61 | $3,742 |
| Ursodiol Generic | 174 | 308 | 33 | $35K |
| Sucralfate Generic | 145 | 375 | 61 | $4,993 |
| Linzess Linaclotide | 142 | 256 | 39 | $128K |
| Azathioprine Generic | 140 | 381 | 37 | $7,855 |
| Mesalamine Generic | 119 | 273 | 29 | $94K |
| Colestipol Hcl Generic | 86 | 162 | 29 | $6,660 |
| Creon Lipase/Protease/Amylase | 85 | 105 | 12 | $135K |
| Esomeprazole Magnesium Generic | 58 | 150 | 14 | $2,313 |
| Mesalamine Dr Mesalamine | 38 | 72 | Under 11 | $16K |
Brand drugs: 672 claims; generic drugs: 4,958 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirish A Amin $16K ($16K in general payments such as food, travel and fees) from 23 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $5,328.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 15 | $5,328 |
| Phathom Pharmaceuticals, Inc. PHAT | 19 | $5,212 |
| Abbvie Inc. ABBV | 70 | $1,234 |
| Janssen Biotech, Inc. JNJ | 41 | $1,026 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 38 | $530 |
| Ardelyx, Inc. ARDX | 17 | $339 |
| Celltrion USA Inc. 068270.KS | 16 | $337 |
| Pfizer Inc. PFE | 17 | $331 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $306 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 15 | $226 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.